Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
3
×
life sciences
3
×
national blog main
boston
boston blog main
boston top stories
deals
investing
san diego blog main
san diego top stories
startups
480 biomedical
achaogen
adams street partners
antibiotics
arsenal medical
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
biotech ipos
bob langer
chronic rhinosinusitis
covid-19
drug delivery
drug resistance
drugs
dyne therapeutics
genzyme
george whitesides
hatteras venture partners
inflammation
ipo
keros therapeutics
lyra therapeutics
lyzz capital
macrolide pharmaceuticals
medical device
melinta therapeutics
meropenem
What
company
3
×
therapeutics
3
×
developing
drug
ipo
medicines
million
raised
bacteria
biopharma
biotech
brings
business
debut
disease
disorders
dyne
dyne’s
exited
fighting
genetic
infections
infectious
late
launches
lyra
markets
melinta
muscle
muscular
new
nose
noses
persistently
preclinical
products
public
qpex
raises
rare
Language
unset
Current search:
therapeutics
×
company
×
" life sciences "
×
fda
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections